Incyte Corp. (INCY)
93.01
+0.47
(+0.51%)
USD |
NASDAQ |
Mar 16, 16:00
93.01
0.00 (0.00%)
After-Hours: 18:38
Incyte Profit Margin (Quarterly) : 19.86% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 34.40% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Insmed, Inc. | -124.5% |
| Madrigal Pharmaceuticals, Inc. | -18.24% |
| MacroGenics, Inc. | -34.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.48% |
| Return on Assets | 21.19% |
| Return on Invested Capital | 30.14% |
| Gross Profit Margin (Quarterly) | 90.88% |
| Operating Margin (Quarterly) | 25.48% |
| Return on Net Operating Assets | 63.24% |